Literature DB >> 23036356

Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.

Neal H Shorstein1, Kevin L Winthrop2, Lisa J Herrinton2.   

Abstract

PURPOSE: To evaluate post-cataract-surgery endophthalmitis rates in relation to changing practice patterns in antibiotic administration.
SETTING: Kaiser Permanente, Diablo Service Area, California.
DESIGN: Ecological time-trend study.
METHODS: During 2007 through 2011, 3 time periods were identified based on increasing adoption of intracameral injections after phacoemulsification cataract surgery. In 2007, patients primarily received postoperative antibiotic drops without intracameral injection. During 2008 and 2009, in addition to the surgeons' usual postoperative topical drop regimen, patients received intracameral cefuroxime unless contraindicated by allergy or posterior capsule rupture (PCR). During 2010 and 2011, all patients received an intracameral injection of cefuroxime, moxifloxacin, or vancomycin while topical antibiotics were used according to surgeon preference. The rates of postoperative endophthalmitis during these 3 periods were calculated. Also evaluated separately were consecutive patients without PCR from a subgroup of 3 surgeons who used intracameral injection alone without perioperative topical antibiotics.
RESULTS: Nineteen cases of endophthalmitis occurred in 16,264 cataract surgeries. The respective rates per 1000 during the 3 time periods (2007, 2008 and 2009, 2010 and 2011) were as follows: 3.13 (95% confidence interval [CI], 1.43-5.93); 1.43 (95% CI, 0.66-2.72); 0.14 (95% CI, 0-0.78). One case of endophthalmitis was observed in 2038 patients without PCR who received intracameral injection only without topical antibiotics (rate per 1000: 0.49; 95% CI, 0.01-2.73).
CONCLUSIONS: The adoption of intracameral antibiotic injection coincided with a decline in the rate of postoperative endophthalmitis, and a low infection rate was observed with intracameral injection alone.
Copyright © 2012 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036356     DOI: 10.1016/j.jcrs.2012.07.031

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  45 in total

1.  A Financial Evaluation of the Centralized Repackaging of Intracameral Moxifloxacin for Cataract Surgery and Its Impact on Cost Reduction.

Authors:  Alexander J Radish; Chad Smith; Ann M Parks; Anne Graff LaDisa
Journal:  Hosp Pharm       Date:  2018-02-12

Review 2.  Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery.

Authors:  Emily W Gower; Kristina Lindsley; Samantha E Tulenko; Afshan A Nanji; Ilya Leyngold; Peter J McDonnell
Journal:  Cochrane Database Syst Rev       Date:  2017-02-13

3.  Safety of prophylactic intracameral moxifloxacin ophthalmic solution after cataract surgery in patients with penetrating keratoplasty.

Authors:  Osman Sevki Arslan; Ceyhun Arici; Mustafa Unal; Erdogan Cicik; Mehmet Serhat Mangan; Eray Atalay
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

4.  Pathogens and antibiotic sensitivities in endophthalmitis.

Authors:  Geraldine R Slean; Neal H Shorstein; Liyan Liu; John F Paschal; Kevin L Winthrop; Lisa J Herrinton
Journal:  Clin Exp Ophthalmol       Date:  2017-01-31       Impact factor: 4.207

5.  Evaluation of bacterial contamination rate of the anterior chamber during phacoemulsification surgery using an automated microbial detection system.

Authors:  Ibrahim Kocak; Funda Kocak; Bahri Teker; Ali Aydin; Faruk Kaya; Hakan Baybora
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

6.  Late surgical complications to endophthalmitis after cataract surgery in the post-EVS era.

Authors:  Søren Solborg Bjerrum; Jens F Kiilgaard; Morten La Cour
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-15       Impact factor: 3.117

7.  Intracameral cefuroxime and the incidence of post-cataract endophthalmitis: an Israeli experience.

Authors:  Gabriel Katz; Sharon Blum; Omer Leeva; Ruth Axer-Siegel; Joseph Moisseiev; Gili Tesler; Rita Ehrlich
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-24       Impact factor: 3.117

8.  Intracameral Antibiotics in the Shadow of Hemorrhagic Occlusive Retinal Vasculitis.

Authors:  Ayman Naseri; Ronald B Melles; Neal H Shorstein
Journal:  Ophthalmology       Date:  2017-05       Impact factor: 12.079

9.  Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery.

Authors:  Andrew Xingyu Zhou; Wyatt Boyer Messenger; Steven Sargent; Balamurali Krishna Ambati
Journal:  Int Ophthalmol       Date:  2015-11-14       Impact factor: 2.031

Review 10.  Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.